Molecular mechanisms underlying human circadian sleep disorders
人类昼夜节律睡眠障碍的分子机制
基本信息
- 批准号:10256761
- 负责人:
- 金额:$ 30.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-04 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccidentsAdvanced Sleep Phase SyndromeAffectAllelesAmino AcidsAnimal ModelBiological AssayCRISPR/Cas technologyCell Culture TechniquesCell LineCell modelCellsCircadian RhythmsClinicalClock proteinClustered Regularly Interspaced Short Palindromic RepeatsDataDeubiquitinationDimerizationDiseaseEnzymesEquilibriumEventGene PoolGenesGeneticGenetic VariationHumanHuman GenomeIndividualKineticsLaboratoriesLeadLengthLibrariesLinkMalignant NeoplasmsMammalsMediatingMetabolic DiseasesMissense MutationModelingMolecularMusMutant Strains MiceMutationNamesPathologicPatientsPerformancePerformance at workPeriodicityPhasePhenotypePhosphorylationPhosphotransferasesPhysiologyPost-Translational RegulationProcessProteinsReactionRegulationReporterRiskRoleS PhaseSingle Nucleotide PolymorphismSiteSleep DisordersSleep Wake CycleSystemTestingUbiquitinationVariantWorkYeastsadverse outcomebeta-Transducin Repeat-Containing Proteinscircadiancircadian pacemakercritical periodeffective therapyfallsin vivo evaluationmolecular modelingmouse modelmutantnovelpolymerizationrepairedscreeningsleep qualitytraffickingubiquitin-protein ligase
项目摘要
Project Summary/Abstract
Adverse consequences from having a faulty circadian clock include compromised sleep quality, poor
performance, and increased risk for accidents in the short-term, and metabolic diseases and cancer in the
long-term. However, our understanding of circadian sleep disorders—and thus our ability to develop treatments
for them—is limited by the incompleteness of our molecular models and our dearth of animal models. For
example, many patients with circadian sleep disorders have wake-sleep cycles that shift daily in an
unpredictable manner. Yet there were no animal models that emulated such unstable rhythms until our
laboratory developed one in the last two years. There may be other human circadian disorders that go
unrecognized or are poorly understood because our limited set of animal models fall far short of matching the
diversity of the human gene pool. We propose to study a highly diverse set of mutations and single-nucleotide
polymorphisms (SNPs) to elucidate their effect on circadian clock function. We would thus enhance the
understanding of diverse chronotypes and sleep disorders in humans and pave the way for developing
effective treatments.
Specific Aim 1: Identify genetic variations in PER that may be associated with human circadian
sleep disorders. Because it would be prohibitively expensive to use animal models to recapitulate all known
SNPs and mutations in human clock genes, we will first characterize a large number of important variants in
cell culture, using U2OS and MEFs, cell lines widely accepted as models for circadian rhythms. Our focus will
be on SNPs or mutations in Period (Per) genes because Per1 and 2 are the most important mammalian genes
in determining the clock’s period and phase, and hundreds of variants of each gene are known to exist. We will
use the CRISPR/Cas9 technology to reproduce diverse variants in clock cells, and we will evaluate their
circadian phenotypes. We have already identified a Per1 deletion mutant revealing a novel motif critical for
phosphorylation, leading us to a novel hypothesis for how PER phosphorylation is dynamically regulated. We
will test this hypothesis and continue to study other mechanisms of posttranslational regulation critical for the
clock. We will also reproduce a select set of variants in mice for in vivo testing.
Specific Aim 2: Identify key regulators of robust and timed proteasomal degradation of PER. Our
previous and ongoing studies suggest that the circadian clock is dependent on rhythms of the core clock
protein PER, and its proteasomal degradation is regulated by both ubiquitination and deubiquitination. We
propose to conduct a systematic search for E3 ligases that regulate PER ubiquitination and degradation, and
to test their function in cell models, along with the functions of candidate deubiquitnases. In Aim 1, we will
identify key regulatory sites within PER, while in Aim 2, we will identify key enzymes involved in that regulation.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHOOGON LEE其他文献
CHOOGON LEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHOOGON LEE', 18)}}的其他基金
A novel cell-based platform to study human circadian disorders
研究人类昼夜节律紊乱的新型细胞平台
- 批准号:
10736091 - 财政年份:2023
- 资助金额:
$ 30.32万 - 项目类别:
Molecular mechanisms underlying human circadian sleep disorders
人类昼夜节律睡眠障碍的分子机制
- 批准号:
10474631 - 财政年份:2019
- 资助金额:
$ 30.32万 - 项目类别:
Molecular mechanisms underlying human circadian sleep disorders
人类昼夜节律睡眠障碍的分子机制
- 批准号:
10006843 - 财政年份:2019
- 资助金额:
$ 30.32万 - 项目类别:
Regulation of mammalian cell physiology by a novel synthetic circadian clock
通过新型合成生物钟调节哺乳动物细胞生理学
- 批准号:
9226127 - 财政年份:2016
- 资助金额:
$ 30.32万 - 项目类别:
Regulation of mammalian cell physiology by a novel synthetic circadian clock
通过新型合成生物钟调节哺乳动物细胞生理学
- 批准号:
9341405 - 财政年份:2016
- 资助金额:
$ 30.32万 - 项目类别:
Roles of casein kinase le/d and b-Trcp in the mammalian circadian clock
酪蛋白激酶 le/d 和 b-Trcp 在哺乳动物生物钟中的作用
- 批准号:
7770892 - 财政年份:2006
- 资助金额:
$ 30.32万 - 项目类别:
Roles of casein kinase le/d and b-Trcp in the mammalian circadian clock
酪蛋白激酶 le/d 和 b-Trcp 在哺乳动物生物钟中的作用
- 批准号:
7367819 - 财政年份:2006
- 资助金额:
$ 30.32万 - 项目类别:
Roles of casein kinase le/d and b-Trcp in the mammalian circadian clock
酪蛋白激酶 le/d 和 b-Trcp 在哺乳动物生物钟中的作用
- 批准号:
7567600 - 财政年份:2006
- 资助金额:
$ 30.32万 - 项目类别:
Roles of casein kinase le/d and b-Trcp in the mammalian circadian clock
酪蛋白激酶 le/d 和 b-Trcp 在哺乳动物生物钟中的作用
- 批准号:
7147783 - 财政年份:2006
- 资助金额:
$ 30.32万 - 项目类别:
Roles of casein kinase le/d and b-Trcp in the mammalian circadian clock
酪蛋白激酶 le/d 和 b-Trcp 在哺乳动物生物钟中的作用
- 批准号:
7234070 - 财政年份:2006
- 资助金额:
$ 30.32万 - 项目类别:
相似海外基金
Characterization of Advanced Sleep Phase Syndrome
高级睡眠阶段综合症的特征
- 批准号:
6383193 - 财政年份:1997
- 资助金额:
$ 30.32万 - 项目类别:
Characterization of Advanced Sleep Phase Syndrome
高级睡眠阶段综合症的特征
- 批准号:
6804572 - 财政年份:1997
- 资助金额:
$ 30.32万 - 项目类别:
Characterization of familial advanced sleep phase syndrome
家族性睡眠时相提前综合征的特征
- 批准号:
7526360 - 财政年份:1997
- 资助金额:
$ 30.32万 - 项目类别:
Characterization of familial advanced sleep phase syndrome
家族性睡眠时相提前综合征的特征
- 批准号:
7689235 - 财政年份:1997
- 资助金额:
$ 30.32万 - 项目类别:
Characterization of Advanced Sleep Phase Syndrome
高级睡眠阶段综合症的特征
- 批准号:
6951463 - 财政年份:1997
- 资助金额:
$ 30.32万 - 项目类别:
Characterization of familial advanced sleep phase syndrome
家族性睡眠时相提前综合征的特征
- 批准号:
8091290 - 财政年份:1997
- 资助金额:
$ 30.32万 - 项目类别:
Characterization of Familial Advanced Sleep Phase Syndrome
家族性晚期睡眠阶段综合征的特征
- 批准号:
8812955 - 财政年份:1997
- 资助金额:
$ 30.32万 - 项目类别:
Characterization of Advanced Sleep Phase Syndrome
高级睡眠阶段综合症的特征
- 批准号:
6527134 - 财政年份:1997
- 资助金额:
$ 30.32万 - 项目类别:
Characterization of familial advanced sleep phase syndrome
家族性睡眠时相提前综合征的特征
- 批准号:
8282728 - 财政年份:1997
- 资助金额:
$ 30.32万 - 项目类别:
Characterization of Advanced Sleep Phase Syndrome
高级睡眠阶段综合症的特征
- 批准号:
6653108 - 财政年份:1997
- 资助金额:
$ 30.32万 - 项目类别:














{{item.name}}会员




